Research Alliance Corporation III (RACC)
| Market Cap | 202.62M |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 9.10M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 56,900 |
| Open | 23.00 |
| Previous Close | 22.90 |
| Day's Range | 21.40 - 24.75 |
| 52-Week Range | 10.21 - 33.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About RACC
Research Alliance Corporation III focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was incorporated in 2026 and is based in New York, New York.
News
Research Alliance Corporation III trading resumes
10:13 EDT Research Alliance Corporation III (RACC) trading resumes
Research Alliance Corporation III trading halted, volatility trading pause
10:08 EDT Research Alliance Corporation III (RACC) trading halted, volatility trading pause
OHB Pediatrics to go public through Research Alliance Corporation III pact
OHB Pediatrics and Research Alliance Corporation III (RACC) announced that they have entered into a definitive business combination agreement. In connection with consummation of the transaction, which...
Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome
Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance Corporation III's (Nasdaq: RACC) (“RACC”) trust account that i...
Research Alliance Corporation III trading resumes
14:55 EDT Research Alliance Corporation III (RACC) trading resumes
Research Alliance Corporation III trading halted, volatility trading pause
14:50 EDT Research Alliance Corporation III (RACC) trading halted, volatility trading pause
RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING
NEW YORK, May 20, 2026 /PRNewswire/ -- Research Alliance Corporation III (the "Company"), a special purpose acquisition company, announced today the pricing of its initial public offering of 7,500,000...
Research Alliance Corporation III IPO Registration Document (S-1)
Research Alliance Corporation III has filed to go public with an IPO on the NASDAQ